Skip to main content
JADPRO Live 2025 Main banner
Icon Legend
Presentation Icons
CE Credit Available
CE Credit Available
Pharmacology Credit Available
Pharmacology Credit Available
Poster Presentation
Poster Presentation
Surgical Oncology
Surgical Oncology
Radiation Oncology
Radiation Oncology
Ticketed Session - Additional Fee
Ticketed Session - Additional Fee
Capturing for On Demand
Capturing for On Demand
Ticketed Event - Included w. Registration
Ticketed Event - Included w. Registration

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Friday, October 24, 2025
  • 6:30 AM - 4:35 PM ET
    Exhibitor Registration & Lead Retrieval
  • 6:30 AM - 5:30 PM ET
    Conference Registration
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity/Non-CE Satellite Symposium:
    A Treatment Option for Adult Patients With Locally Advanced or Metastatic Urothelial Cancer
    Merck & Co., Inc.

    Seating available on first-come, first-served basis
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity/Non-CE Satellite Symposium:
    Redefining Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma: A Focus on the Outcomes of Transplant-Eligible and Transplant-Ineligible Patients as seen in the PERSEUS and MAIA Trials
    Johnson & Johnson

    Seating available on first-come, first-served basis
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity/Non-CE Satellite Symposium:
    Reducing access barriers: New FDA label updates on cell therapy post-treatment monitoring requirements
    Bristol Myers Squibb

    Seating available on first-come, first-served basis
  • 7:00 AM - 8:15 AM ET
    Breakfast Activity/Non-CE Satellite Symposium:
    Supporting Patients With HR+/HER2- mBC Throughout Their Treatment Journey
    Pfizer, Inc.

    Seating available on first-come, first-served basis
  • 7:00 AM - 8:20 AM ET
    Exhibit Hall Open &
    Continental Breakfast
  • 7:00 AM - 8:20 AM ET
    Professional Profile Pavilion
  • 7:30 AM - 8:00 AM ET
    APSHO Pop-Up: AI in Oncology - Let's Talk
  • 8:30 AM - 8:35 AM ET
    Welcome & Opening Remarks
  • 8:30 AM - 9:45 AM ET
    The Power of a Unified Voice: Optimizing the AP Role Through Society Collaborations
  • 9:55 AM - 10:55 AM ET
    A Team-Based Approach to the Management of Acute and Late Radiation Side Effects
  • 9:55 AM - 10:55 AM ET
    Navigating Relapsed/Refractory Multiple Myeloma: Evidence-Based Approaches in a Changing Landscape
  • 9:55 AM - 10:55 AM ET
    New Drug Updates in Solid Tumors
  • 10:00 AM - 4:30 PM ET
    Braindate Lounge
  • 11:00 AM - 11:30 AM ET
    APSHO Meet & Greet: Awards & Recognition Committee
  • 11:00 AM - 12:00 PM ET
    Exhibit Hall Open &
    Refreshment Break
  • 11:00 AM - 12:00 PM ET
    Professional Profile Pavilion: The Art of Compensation Negotiation
  • 11:05 AM - 11:35 AM ET
    Exhibit Hall Presentation:
    Exploring the Role of c-Met Protein Overexpression in the NSCLC Treatment Landscape
    AbbVie
  • 11:05 AM - 11:35 AM ET
    Exhibit Hall Presentation:
    Long Term Monitoring and Transitions of Care after CARVYKTI
    Johnson & Johnson
  • 11:05 AM - 11:50 AM ET
    Exhibit Hall Presentation:
    Offering TRODELVY for Appropriate Patients With Pretreated HR+/HER2- mBC and mTNBC
    Gilead and Kite Oncology
  • 11:05 AM - 12:00 PM ET
    Moderated Posters
  • 11:30 AM - 12:00 PM ET
    APSHO Meet & Greet: Communications Committee
  • 12:10 PM - 12:55 PM ET
    Navigating p16-Positive Oropharyngeal Cancer: A Multidisciplinary Patient-Centered Approach
  • 12:10 PM - 12:55 PM ET
    Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer
  • 12:10 PM - 12:55 PM ET
    The Lowdown on Low Counts: Navigating Complex Cases in Therapy-Related Cytopenias
  • 1:00 PM - 2:20 PM ET
    Exhibit Hall Open & Lunch
  • 1:00 PM - 2:20 PM ET
    Lunch Activity/Non-CE Satellite Symposium:
    A 2L Treatment Option for HR+/HER2− aBC or mBC With PIK3CA, AKT1, or PTEN Alterations Following Progression on or After ET ± CDK4/6i
    AstraZeneca

    Seating available on first-come, first-served basis
  • 1:00 PM - 2:20 PM ET
    Lunch Activity/Non-CE Satellite Symposium:
    A Treatment Option for Adults with Certain R/R DLBCL After ≥2 Prior Lines of Systemic Therapy
    Pfizer, Inc.

    Seating available on first-come, first-served basis
  • 1:00 PM - 2:20 PM ET
    Lunch Activity/Non-CE Satellite Symposium:
    Addressing Real-World Clinical Evidence in Polycythemia Vera and Myelofibrosis: A Case-Based Discussion on Clinical Decision Making
    Incyte Corporation

    Seating available on first-come, first-served basis
  • 1:00 PM - 2:20 PM ET
    Lunch Activity/Non-CE Satellite Symposium:
    Alternative Routes of Administration: Advancing Oncology Care with Subcutaneous Immunotherapy
    Bristol Myers Squibb

    Seating available on first-come, first-served basis
  • 1:00 PM - 2:20 PM ET
    Lunch Activity/Non-CE Satellite Symposium:
    Two First-In-Class Treatments for Patients with Relapsed or Refractory Multiple Myeloma
    Johnson & Johnson

    Seating available on first-come, first-served basis
  • 1:00 PM - 2:20 PM ET
    Professional Profile Pavilion
  • 1:30 PM - 2:00 PM ET
    APSHO Meet & Greet: Diversity, Equity, & Inclusion (DEI) Committee
  • 2:00 PM - 2:30 PM ET
    APSHO Meet & Greet: Mentor Match Meet Up
  • 2:30 PM - 3:30 PM ET
    Keynote Address:
    Clinician and Kin: United in Care with the Family Caregiver
  • 3:30 PM - 4:00 PM ET
    APSHO Meet & Greet: Surgical Oncology Committee
  • 3:35 PM - 4:35 PM ET
    Exhibit Hall Open & Refreshment Break
  • 3:35 PM - 4:35 PM ET
    Professional Profile Pavilion: Crafting Your Professional Bio & LinkedIn Profile
  • 3:40 PM - 4:10 PM ET
    Exhibit Hall Presentation:
    Collaborative Melanoma Care: Informing Decisions and Improving Outcomes with the 31-GEP Test
    Castle Biosciences
  • 3:40 PM - 4:10 PM ET
    Exhibit Hall Presentation:
    Head to Head Overall Survival in mCSPC: A Review of Real World Evidence
    Johnson & Johnson
  • 3:40 PM - 4:25 PM ET
    Exhibit Hall Presentation:
    Expanding Beyond Binary: Reframing HER2 Expression in mBC
    Daiichi Sankyo, Inc. and AstraZeneca
  • 4:00 PM - 4:30 PM ET
    APSHO Meet & Greet: APSHO Board of Directors
  • 4:45 PM - 5:45 PM ET
    Multidisciplinary Management of Spinal Metastases: Integrating Surgery and Radiation Therapy
  • 4:45 PM - 5:45 PM ET
    Sequencing Therapies in Non-Hodgkin Lymphomas
  • 4:45 PM - 6:00 PM ET
    Oral Poster Presentations (Part 1)
  • 6:00 PM - 7:00 PM ET
    Independent CE Satellite Symposium:
    Relapsed/Refractory Multiple Myeloma: Evidence-Based Guidelines and Essential Strategies for Optimized Treatment Selection and Sequencing
  • 7:30 PM - 9:00 PM ET
    Independent CE Dinner Satellite Symposium:
    Managing HER2 and TROP2 ADC Adverse Events: Advanced Practice Providers Case Discussions Highlighting the Critical Roles in Patient Care